Judith Wallenstein leads Boston Consulting Group’s CEO Advisory practice in Central Europe, the Middle East, and Africa (CEMA). She is a core member of BCG’s Health Care practice, focused on serving clients in the pharmaceutical industry. Judith is also the Social Impact regional practice leader for CEMA, and the Social Impact node in BCG’s global Corporate Finance and Strategy practice leadership team.

Judith became a BCG Fellow in 2015. During this time, she examined the implications of the sharing economy and the future of work.

Judith’s pharma work centers on strategy, marketing and sales, M&A, and portfolio management. She is passionate about the ever-increasing challenges of product launches in pharma and has served as the firm’s global topic lead for launch excellence in the pharmaceutical sector. She has been involved in a number of major carve-out and divestiture efforts in the industry in recent years.

Most of her client work is focused on consumer health care, immunology, and oncology, as well as on rare disease.

Judith joined BCG's Munich office in 2000. She spent 18 months in the Madrid office and 12 months in the New York office as BHI’s first ambassador in 2005. Her initial career plan had been to become a diplomat before an internship with BCG put her on a different track.

AREAS OF EXPERTISE

  • CEO Advisory/transitions
  • Environmental, social, governance
  • Climate change
  • Carve-outs and divestitures
  • Asset deals
  • Future of work
  • Sharing economy
  • Launch excellence
  • Brand strategy
  • Marketing capabilities
  • Return on marketing investment

EDUCATION

  • Master’s degree, history and German and French literature, Ludwig-Maximilians-Universität
Deep Expertise, Broad Experience